Nyxoah is trading at $1.41, up 10.6%, as healthcare stocks gain amid renewed biotechnology optimism, acquisition activity, and a supportive regulatory backdrop.
- No new company-specific announcement was identified for September 25, 2026.
- Nyxoah’s latest official release was the September 21 CFO transition.
- The September 7 BREATHE-study update is not a same-day catalyst.